Advertisement

Latest News

Jacques-Eric Gottenberg, MD, PhD: Promising Phase 2 Results for Nipocalimab in Sjögren's Treatment

4 hours ago

Jacques-Eric Gottenberg, MD, PhD, discusses the encouraging results of a phase 2 study evaluating nipocalimab for the treatment of Sjögren's syndrome.

COVID-19 Vaccination Shows Favorable Risk-Benefit in Sickle Cell

7 hours ago

A study from the ASH Research Network reports positive antibody response and tolerability after mRNA vaccination in people with sickle cell disease.

Psoriasis, Psoriatic Arthritis Linked to Increased Polyneuropathy Risk

22 hours ago

These data highlight the association between risk of developing polyneuropathy and the presence of psoriasis and psoriatic arthritis.

Late-Onset Psoriasis May Shorten Interval Between Psoriasis and PsA Diagnoses

July 13, 2024

Older age and a greater BMI are associated with having a shorter interval between psoriasis and PsA diagnoses, a study found.

Brendon Neuen, MBBS, PhD: Optimizing Cardiorenal Prognosis with GLP-1, SGLT2 Combination

July 13, 2024

Neuen explains the cardiovascular and kidney benefits of combining SGLT2 inhibitors and GLP-1 receptor agonists in diabetes and the future of combination therapy.

Advertisement
Advertisement